Literature DB >> 16933473

Pulmonary capillaritis and its relationship to development of emphysema in hypocomplementaemic urticarial vasculitis syndrome.

David P J Hunt1, Rimona Weil, Andrew G Nicholson, Margaret M Burke, Ron M Du Bois, Athol U Wells.   

Abstract

Hypocomplementaemic urticarial vasculitis syndrome (HUVS) is a rare disorder characterised by complement activation and the presence of C1q precipitins together with a syndrome of urticarial vasculitis, angioedema, arthralgia, ocular inflammation, glomerulonephritis and obstructive lung disease. The pathophysiology of the obstructive airways disease is poorly understood. We report a 46 year-old woman with HUVS who developed progressive obstructive airways disease. Lung biopsy early in the course of her disease revealed pulmonary capillaritis. The disease progressed despite treatment with steroids and cyclosporin and the patient eventually underwent successful double lung transplantation. The explanted lung showed the coexistence of a patchy active vasculitis with severe panacinar emphysema. This is the first description of the histopathological process of HUVS in an explanted lung. Through analysis of serial histopathological specimens and clinical data we show the evolution of pulmonary capillaritis to emphysema, and demonstrate that active vasculitis can coexist with emphysema in patients with HUVS and obstructive airways disease. We suggest that there is a role for ongoing immunosuppressive therapy in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933473

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  4 in total

Review 1.  Molecular pathogenesis of emphysema.

Authors:  Laimute Taraseviciene-Stewart; Norbert F Voelkel
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

Review 2.  Urticarial vasculitis.

Authors:  Natalie A Brown; John D Carter
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.686

3.  Segmental endobronchial valve therapy for a vasculitis-induced emphysema.

Authors:  Christina Bal; Lisa Göschl; Ruxandra-Iulia Milos; Klaus Gerstbrein; Andreas Kerschbaumer; Marco Idzko; Daniela Gompelmann
Journal:  Respir Med Case Rep       Date:  2022-04-16

4.  Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults.

Authors:  Anna Stainer; Alex Rice; Anand Devaraj; Joseph Luke Barnett; Jacqueline Donovan; Maria Kokosi; Andrew Gordon Nicholson; Tom Cairns; Athol Umfrey Wells; Elisabetta Augusta Renzoni
Journal:  BMC Pulm Med       Date:  2019-10-24       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.